TipRanks
RaQualia Pharma Inc. (JP:4579)
:4579
Japanese Market
4579
RaQualia Pharma Inc.
RESEARCH TOOLSreports
Want to see JP:4579 full AI Analyst Report?

RaQualia Pharma Inc. (4579) Ratios

1 Followers

RaQualia Pharma Inc. Ratios

JP:4579's free cash flow for Q2 2026 was ¥0.76. For the 2026 fiscal year, JP:4579's free cash flow was decreased by ¥ and operating cash flow was ¥-0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.78 4.46 3.82 12.73 9.77
Quick Ratio
 5.62 4.33 3.68 12.35 9.75
Cash Ratio
 4.27 2.54 2.81 9.54 7.44
Solvency Ratio
 0.20 0.21 -0.02 -0.20 1.15
Operating Cash Flow Ratio
 0.47 -0.28 0.15 -1.85 3.00
Short-Term Operating Cash Flow Coverage
 0.82 -0.60 0.35 -56.94 564.92
Net Current Asset Value
¥ 3.01B¥ 2.06B¥ 453.99M¥ 4.20B¥ 4.06B
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.28 0.36 0.05 0.04
Debt-to-Equity Ratio
 0.34 0.42 0.62 0.06 0.04
Debt-to-Capital Ratio
 0.26 0.30 0.38 0.06 0.04
Long-Term Debt-to-Capital Ratio
 0.19 0.24 0.32 <0.01 <0.01
Financial Leverage Ratio
 1.41 1.52 1.73 1.12 1.14
Debt Service Coverage Ratio
 0.90 1.26 0.07 -7.33 101.81
Interest Coverage Ratio
 5.54 8.19 -1.16 -50.50 144.49
Debt to Market Cap
 0.18 0.11 0.38 <0.01 <0.01
Interest Debt Per Share
 105.56 125.00 168.00 17.33 10.89
Net Debt to EBITDA
 -2.23 -0.34 0.60 29.94 -3.44
Profitability Margins
Gross Profit Margin
79.46%82.11%79.86%87.11%92.06%
EBIT Margin
9.49%12.49%-6.87%-15.11%29.37%
EBITDA Margin
21.72%24.75%6.06%-5.88%34.43%
Operating Profit Margin
8.60%12.15%-6.87%-17.74%29.69%
Pretax Profit Margin
10.34%11.00%-11.51%-15.47%29.16%
Net Profit Margin
4.13%6.86%-15.93%-17.02%24.79%
Continuous Operations Profit Margin
4.13%6.86%-15.93%-17.02%24.79%
Net Income Per EBT
39.98%62.36%138.38%110.07%85.00%
EBT Per EBIT
120.22%90.54%167.65%87.16%98.24%
Return on Assets (ROA)
1.46%2.60%-5.13%-4.71%11.56%
Return on Equity (ROE)
2.23%3.96%-8.89%-5.29%13.16%
Return on Capital Employed (ROCE)
3.38%5.24%-2.52%-5.20%15.03%
Return on Invested Capital (ROIC)
1.27%3.07%-2.36%-5.14%12.67%
Return on Tangible Assets
2.17%4.03%-8.60%-4.73%11.61%
Earnings Yield
1.10%1.14%-5.96%-2.18%2.80%
Efficiency Ratios
Receivables Turnover
 4.58 2.06 4.51 3.15 4.84
Payables Turnover
 11.83 9.73 10.55 4.52 1.81
Inventory Turnover
 4.88 4.46 3.73 1.66 27.25
Fixed Asset Turnover
 8.68 9.12 5.87 3.31 7.46
Asset Turnover
 0.35 0.38 0.32 0.28 0.47
Working Capital Turnover Ratio
 0.74 1.03 0.78 0.43 0.74
Cash Conversion Cycle
 123.74 221.23 144.18 255.46 -113.11
Days of Sales Outstanding
 79.78 176.84 80.95 115.80 75.34
Days of Inventory Outstanding
 74.83 81.91 97.83 220.35 13.40
Days of Payables Outstanding
 30.87 37.52 34.60 80.69 201.84
Operating Cycle
 154.61 258.75 178.78 336.16 88.74
Cash Flow Ratios
Operating Cash Flow Per Share
 19.20 -15.05 8.36 -33.26 70.58
Free Cash Flow Per Share
 17.63 -17.90 3.89 -43.54 69.06
CapEx Per Share
 1.56 2.84 4.47 10.28 1.52
Free Cash Flow to Operating Cash Flow
 0.92 1.19 0.47 1.31 0.98
Dividend Paid and CapEx Coverage Ratio
 12.28 -5.29 1.87 -3.23 46.39
Capital Expenditure Coverage Ratio
 12.28 -5.29 1.87 -3.23 46.39
Operating Cash Flow Coverage Ratio
 0.19 -0.12 0.05 -1.95 6.66
Operating Cash Flow to Sales Ratio
 0.13 -0.09 0.06 -0.38 0.51
Free Cash Flow Yield
3.32%-1.77%1.01%-6.33%5.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 62.46 87.60 -16.79 -45.93 35.71
Price-to-Sales (P/S) Ratio
 3.51 6.01 2.67 7.82 8.85
Price-to-Book (P/B) Ratio
 1.86 3.47 1.49 2.43 4.70
Price-to-Free Cash Flow (P/FCF) Ratio
 29.80 -56.43 98.67 -15.80 17.84
Price-to-Operating Cash Flow Ratio
 29.12 -67.09 45.94 -20.69 17.45
Price-to-Earnings Growth (PEG) Ratio
 3.05 -0.58 -0.32 0.32 -8.20
Price-to-Fair Value
 1.86 3.47 1.49 2.43 4.70
Enterprise Value Multiple
 13.91 23.94 44.74 -103.02 22.28
Enterprise Value
 11.93B 23.59B 8.42B 11.52B 22.38B
EV to EBITDA
 14.09 23.94 44.74 -103.02 22.28
EV to Sales
 3.06 5.93 2.71 6.06 7.67
EV to Free Cash Flow
 26.00 -55.63 100.00 -12.24 15.45
EV to Operating Cash Flow
 23.89 -66.14 46.56 -16.03 15.12
Tangible Book Value Per Share
 163.08 133.54 77.07 281.85 260.98
Shareholders’ Equity Per Share
 300.96 291.12 257.35 283.27 262.14
Tax and Other Ratios
Effective Tax Rate
 0.60 0.38 -0.38 -0.10 0.15
Revenue Per Share
 149.87 168.01 143.57 87.99 139.16
Net Income Per Share
 6.20 11.53 -22.87 -14.98 34.50
Tax Burden
 0.40 0.62 1.38 1.10 0.85
Interest Burden
 1.09 0.88 1.68 1.02 0.99
Research & Development to Revenue
 0.43 0.40 0.55 0.72 0.43
SG&A to Revenue
 0.28 0.30 0.32 0.33 0.20
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 3.10 -1.31 -0.37 2.22 1.74
Currency in JPY